Trials / Completed
CompletedNCT01533519
A Dose Escalation Study of Intranasal Neuropeptide Y in Post Traumatic Stress Disorder (PTSD)
A Dose Escalation Study of Intranasal Neuropeptide Y in PTSD
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- James Murrough · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to investigate the safety of intranasal administration of NPY using a dose escalation, randomized, double-blinded, placebo-controlled crossover design in a medication-free, symptomatic PTSD group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Neuropeptide Y | Intranasal administration will be administered with a nasal drug delivery device. |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2012-02-15
- Last updated
- 2016-04-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01533519. Inclusion in this directory is not an endorsement.